Patients with SPS-SD (or mixed SPS syndromes) often had high GAD-Abs, accompanied by intrathecal GAD-Ab synthesis and/or oligoclonal bands, and typically responded to sustained immunotherapies. This evidence concerns the gene GAD1 and Salla disease.